JAAD Game Changers: Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - August 3, 2022 Category: Dermatology Authors: Colleen H. Cotton Source Type: research

Pediatric Game Changers ∗: Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
None disclosed. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - August 3, 2022 Category: Dermatology Authors: Colleen H. Cotton Tags: Pediatric game changers Source Type: research

Topical diphenylcyclopropenone plus topical 0.5 & #37; anthralin versus topical diphenylcyclopropenone alone for the treatment of chronic extensive alopecia areata: A split-scalp, double-blind, controlled study
Conclusions: The combination of DCP and 0.5% anthralin was not superior to DCP alone for the treatment of chronic extensive AA. An increase in side effects – excessive dermatitis and hyperpigmentation – was observed in the combination-treatment group. (Source: International Journal of Trichology)
Source: International Journal of Trichology - May 24, 2022 Category: Dermatology Authors: Rattapon Thuangtong Saroj Suvansuthi Pitchaya Maneeprasopchoke Thanisorn Sukakul Rattiya Techakajornkeart Pichanee Chaweekulrat Supisara Wongdama Daranporn Triwongwaranat Source Type: research

Supravenous Repigmentation of Hair Shafts in a Patient with Regrowing Alopecia Totalis: A Case Report and Hypothesis
Conclusion: Loss of pigmentation and subsequent repigmentation of the hair shaft in regrowing AA is not entirely understood. Initial hair regrowth in AA tends to be fine and depigmented, although the hair will usually regain normal texture and color. Pigmentation following a vein suggests that local temperature may play a role, possibly augmented by corticosteroid induced reduced expression of inflammatory cytokines and endothelial release of the vasoconstrictor hormone endothelin, which stimulates melanogenesis.Skin Appendage Disord (Source: Skin Appendage Disorders)
Source: Skin Appendage Disorders - April 28, 2022 Category: Dermatology Source Type: research

Alopecia areata universalis in the onset of autoimmune polyendocrine syndrome Type III C
Nicoleta Neagu, Silviu Horia Morariu, Alina GramaInternational Journal of Trichology 2022 14(2):62-64 Alopecia areata (AA) is an organ-specific autoimmune disease which affects hair follicles. It usually presents as a transient patchy hair loss, but it can sometimes progress into more severe forms such as AA totalis or AA universalis (AAU). Different autoimmune diseases, as well as autoimmune polyglandular syndromes (APS), have been associated with AA, especially with Type I and Type II APS. Herein, we describe the case of a 16-year-old boy with a severe form of AAU and early onset of adult APS, Type III C. As far as we a...
Source: International Journal of Trichology - April 4, 2022 Category: Dermatology Authors: Nicoleta Neagu Silviu Horia Morariu Alina Grama Source Type: research

Could mean platelet volume be used as a marker for activity and severity index of alopecia areata?
CONCLUSION: MPV is helpful in assessing clinical activity in patients with AA. However, prospective studies involving more patients are needed to support our findings.PMID:35286039 | DOI:10.24953/turkjped.2017.271 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - March 14, 2022 Category: Pediatrics Authors: Nebahat Demet Akpolat Source Type: research

Could mean platelet volume be used as a marker for activity and severity index of alopecia areata?
CONCLUSION: MPV is helpful in assessing clinical activity in patients with AA. However, prospective studies involving more patients are needed to support our findings.PMID:35286039 | DOI:10.24953/turkjped.2017.271 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - March 14, 2022 Category: Pediatrics Authors: Nebahat Demet Akpolat Source Type: research